Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline-rifampicin vs trimethoprim-rifampicin for MRSA decolonization
NCT05268120Recruiting
- Sponsor
- Leiden University Medical Center
- Start
- Jul 2022
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of doxycycline and trimethoprim in Staphylococcus aureus colonization, sponsored by Leiden University Medical Center. Primary endpoint: Success rate of MRSA decolonization. Started Jul 2022; status: recruiting.
02
Drugs
doxycyclinetrimethoprim
03
Conditions
Staphylococcus aureus colonization
Beyond the preview
Go deeper on NCT05268120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05268120.